Current management of esophageal cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Effect of preoperative single-dose corticosteroid administration on postoperative morbidity following esophagectomy.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2010
   Pooled it
2. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
   Trial
3. Development of a Giant Stomach in the Thoracic Cavity After Esophagectomy: A Rare Pulmonary Complication.Lung India : official organ of Indian Chest Society · 2026
   Article
4. Clinical value of lymph node dissection for stage T1b mid-thoracic esophageal squamous cell carcinoma.Journal of gastrointestinal oncology · 2021
   Article
5. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer.Annals of gastroenterological surgery · 2020
   Review
6. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.Molecular medicine reports · 2016
   Article
7. Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.Scientific reports · 2014
   Article
8. Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo.World journal of gastroenterology · 2013
   Article
9. New and emerging combination therapies for esophageal cancer.Cancer management and research · 2013
   Article
10. PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma.BMC cancer · 2012
    Article
11. Management of oesophageal cancer.The Indian journal of surgery · 2009
    Article
12. Comparison of the outcomes between open and minimally invasive esophagectomy.Annals of surgery · 2007
    Article
13. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2006
    Article
14. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma.Journal of clinical pathology · 2006
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as